It certainly wasn't a good week for equity investors with macroeconomic factors weighing heavily on the capital markets and major indices giving back all the gains they had made so far this year. Not surprisingly, the biotech sector found itself dragged down in the vortex. A market correction had always been anticipated, but it didn't ameliorate how deep the markets tumbled as investors rushed to sell their equities.